Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001161697-22-000548
Filing Date
2022-11-15
Accepted
2022-11-15 17:00:37
Documents
1
Period of Report
2022-11-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 FOR 11-11-2022 form4.html 4  
1 FORM 4 FOR 11-11-2022 form4.xml 4 3561
  Complete submission text file 0001161697-22-000548.txt   5190
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134
Business Address
DENKHAUS DONALD A (Reporting) CIK: 0001278439 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33057 | Film No.: 221391912

Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Issuer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations